Primary clostridium difficile infection in patients with ulcerative colitis: Case report and literature review

Xizhuang Gao,Huihui Zhou,Zongjing Hu,Quanyi Wang,Yun Chen,Fengqin Zh,Guangxi Zhou
DOI: https://doi.org/10.1097/md.0000000000036693
IF: 1.6
2024-02-10
Medicine
Abstract:Inflammatory bowel disease (IBD) is a group of chronic diseases that includes Ulcerative Colitis (UC) and Crohn Disease (CD). Although the precise mechanisms of these diseases are not fully understood, research suggests that genetics, immune system abnormalities, environmental factors, and gut microbiota may play crucial roles in their development. Abnormal immune responses in IBD patients result in persistent inflammation of the intestinal mucosa, which can potentially affect the entire gastrointestinal tract. UC, a subtype of IBD, predominantly affects the colon and rectum. Typical symptoms include abdominal pain, diarrhea, rectal bleeding, anemia, and fatigue. In UC, inflammation usually spreads continuously, starting from the rectum and extending upwards to various segments of the colon. Treatment strategies aim to reduce inflammation, alleviate symptoms, manage the disease, and enhance the quality of life [ 1 ]
medicine, general & internal
What problem does this paper attempt to address?